Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

1.

Effects of Clozapine on Perceptual Abnormalities and Sensory Gating: A Preliminary Cross-Sectional Study in Schizophrenia.

Micoulaud-Franchi JA, Aramaki M, Geoffroy PA, Richieri R, Cermolacce M, Faget C, Ystad S, Kronland-Martinet R, Lancon C, Vion-Dury J.

J Clin Psychopharmacol. 2015 Jan 13. [Epub ahead of print]

PMID:
25587694
[PubMed - as supplied by publisher]
2.

Determinants of brain SPECT perfusion and connectivity in treatment-resistant depression.

Richieri R, Boyer L, Faget-Agius C, Farisse J, Mundler O, Lançon C, Guedj E.

Psychiatry Res. 2014 Dec 3. pii: S0925-4927(14)00310-2. doi: 10.1016/j.pscychresns.2014.11.013. [Epub ahead of print]

PMID:
25561373
[PubMed - as supplied by publisher]
3.

Perceptually or conceptually driven recognition: On the specificities of the memory deficit in schizophrenia.

Guillaume F, Thomas E, Faget C, Richieri R, Lançon C.

Psychiatry Res. 2014 Dec 8. pii: S0165-1781(14)00953-6. doi: 10.1016/j.psychres.2014.11.060. [Epub ahead of print]

PMID:
25535008
[PubMed - as supplied by publisher]
4.

Risk factors for treatment resistance in unipolar depression: a systematic review.

Bennabi D, Aouizerate B, El-Hage W, Doumy O, Moliere F, Courtet P, Nieto I, Bellivier F, Bubrovsky M, Vaiva G, Holztmann J, Bougerol T, Richieri R, Lancon C, Camus V, Saba G, Haesbaert F, d'Amato T, Charpeaud T, Llorca PM, Leboyer M, Haffen E.

J Affect Disord. 2015 Jan;171:137-41. doi: 10.1016/j.jad.2014.09.020. Epub 2014 Oct 8. Review.

PMID:
25305428
[PubMed - in process]
5.

Validation of the French sensory gating inventory: A confirmatory factor analysis.

Micoulaud-Franchi JA, Hetrick WP, Boyer L, Bolbecker A, Aramaki M, Ystad S, Richieri R, El-Kaim A, Faget C, Faugere M, Cermolacce M, Kronland-Martinet R, Lancon C, Vion-Dury J.

Psychiatry Res. 2014 Dec 30;220(3):1106-12. doi: 10.1016/j.psychres.2014.08.025. Epub 2014 Sep 3.

PMID:
25223255
[PubMed - in process]
6.

Neurophysiological correlates of metabolic syndrome and cognitive impairment in schizophrenia: a structural equation modeling approach.

Boyer L, Testart J, Michel P, Richieri R, Faget-Agius C, Vanoye V, Auquier P, Lancon C, Guedj E.

Psychoneuroendocrinology. 2014 Dec;50:95-105. doi: 10.1016/j.psyneuen.2014.07.019. Epub 2014 Aug 10.

PMID:
25199983
[PubMed - in process]
7.

Ketamine administration in depressive disorders: a systematic review and meta-analysis.

Fond G, Loundou A, Rabu C, Macgregor A, Lançon C, Brittner M, Micoulaud-Franchi JA, Richieri R, Courtet P, Abbar M, Roger M, Leboyer M, Boyer L.

Psychopharmacology (Berl). 2014 Sep;231(18):3663-76. doi: 10.1007/s00213-014-3664-5. Epub 2014 Jul 20.

PMID:
25038867
[PubMed - in process]
8.

Do schizophrenia patients with low P50-suppression report more perceptual anomalies with the sensory gating inventory?

Micoulaud-Franchi JA, Hetrick WP, Aramaki M, Bolbecker A, Boyer L, Ystad S, Kronland-Martinet R, Richieri R, Faget C, Faugere M, El-Kaim A, Cermolacce M, Lancon C, Vion-Dury J.

Schizophr Res. 2014 Aug;157(1-3):157-62. doi: 10.1016/j.schres.2014.05.013. Epub 2014 Jun 2.

PMID:
24893905
[PubMed - in process]
9.

[Ketamine in acute and severe major depressive disorder].

Brittner M, Micoulaud-Franchi JA, Richieri R, Boyer L, Adida M, Lancon C, Fond G.

Presse Med. 2014 May;43(5):492-500. doi: 10.1016/j.lpm.2013.11.013. Epub 2014 Mar 12. Review. French.

PMID:
24630265
[PubMed - indexed for MEDLINE]
10.

Resistant bipolar depressive disorder: case analysis of adjunctive transcranial magnetic stimulation efficiency in medical comorbid conditions.

Zendjidjian XY, Lodovighi MA, Richieri R, Guedj E, Boyer L, Dassa D, Lançon C.

Bipolar Disord. 2014 Mar;16(2):211-3. doi: 10.1111/bdi.12170. Epub 2013 Dec 18. No abstract available.

PMID:
24350675
[PubMed - indexed for MEDLINE]
11.

Structural and functional reorganization of working memory system during the first decade in schizophrenia. A cross-sectional study.

Faget-Agius C, Boyer L, Lançon C, Richieri R, Fassio E, Soulier E, Chanoine V, Auquier P, Ranjeva JP, Guye M.

Schizophr Res. 2013 Dec;151(1-3):48-60. doi: 10.1016/j.schres.2013.10.023. Epub 2013 Nov 11.

PMID:
24230490
[PubMed - indexed for MEDLINE]
12.

Quality of life and other outcome measures in caregivers of patients with schizophrenia.

Testart J, Richieri R, Caqueo-Urízar A, Lancon C, Auquier P, Boyer L.

Expert Rev Pharmacoecon Outcomes Res. 2013 Oct;13(5):641-9. doi: 10.1586/14737167.2013.838022. Epub 2013 Oct 7. Review.

PMID:
24098967
[PubMed - indexed for MEDLINE]
13.

[Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].

Dumas R, Boyer L, Richieri R, Guedj E, Auquier P, Lançon C.

Encephale. 2014 Feb;40(1):74-80. doi: 10.1016/j.encep.2013.04.004. Epub 2013 Oct 1. French.

PMID:
24091070
[PubMed - indexed for MEDLINE]
14.

Association of metabolic syndrome and inflammation with neurocognition in patients with schizophrenia.

Boyer L, Richieri R, Dassa D, Boucekine M, Fernandez J, Vaillant F, Padovani R, Auquier P, Lancon C.

Psychiatry Res. 2013 Dec 15;210(2):381-6. doi: 10.1016/j.psychres.2013.06.020. Epub 2013 Jul 10.

PMID:
23850204
[PubMed - indexed for MEDLINE]
15.

[Interactive rTMS protocols in psychiatry].

Micoulaud-Franchi JA, Richieri R, Lancon C, Vion-Dury J.

Encephale. 2013 Dec;39(6):426-31. doi: 10.1016/j.encep.2013.04.009. Epub 2013 Jun 28. Review. French.

PMID:
23810752
[PubMed - indexed for MEDLINE]
16.

Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis.

Richieri R, Guedj E, Michel P, Loundou A, Auquier P, Lançon C, Boyer L.

J Affect Disord. 2013 Oct;151(1):129-35. doi: 10.1016/j.jad.2013.05.062. Epub 2013 Jun 18.

PMID:
23790811
[PubMed - indexed for MEDLINE]
17.

Single-photon emission computed tomography findings in a patient with Fahr disease associated with a schizophrenia-like psychosis.

Boyer L, Guedj E, Richieri R, Vaillant F, Lancon C.

J Clin Psychiatry. 2013 May;74(5):e431-2. doi: 10.4088/JCP.12cr08345. No abstract available.

PMID:
23759462
[PubMed - indexed for MEDLINE]
18.

Validation of a functional remission threshold for the Functional Remission of General Schizophrenia (FROGS) scale.

Boyer L, Richieri R, Guedj E, Faget-Agius C, Loundou A, Llorca PM, Auquier P, Lançon C.

Compr Psychiatry. 2013 Oct;54(7):1016-22. doi: 10.1016/j.comppsych.2013.04.008. Epub 2013 May 31.

PMID:
23731897
[PubMed - indexed for MEDLINE]
19.

Left temporopolar impairment in a case of posttraumatic hypersomnia.

Farisse J, Guedj E, Richieri R, De Cock VC, Lancon C, Boyer L.

J Head Trauma Rehabil. 2013 Nov-Dec;28(6):473-5. doi: 10.1097/HTR.0b013e3182803eda.

PMID:
23407426
[PubMed - indexed for MEDLINE]
20.

Are cardiovascular risk factors associated with verbal learning and memory impairment in patients with schizophrenia? A cross-sectional study.

Lancon C, Dassa D, Fernandez J, Richieri R, Padovani R, Boyer L.

Cardiovasc Psychiatry Neurol. 2012;2012:204043. doi: 10.1155/2012/204043. Epub 2012 Nov 19.

PMID:
23227310
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk